Important Safety Information

About KEVEYIS

Gain greater control over Primary Periodic Paralysis with KEVEYIS®

KEVEYIS is proven to treat PPP1,2

KEVEYIS is a daily pill proven to reduce the number, severity and length of PPP episodes in 2 clinical studies.1,2 It’s the first drug approved by the FDA for treatment of PPP.1

When compared with an inactive pill in a 9-week study:

A second study confirmed the results of the first study.3

Taking KEVEYIS

KEVEYIS is a pill that you take by mouth once or twice a day, depending on what your doctor prescribed. Treatment with KEVEYIS is personalized, so your doctor can change your dose to find what’s right for you.1

Before you start KEVEYIS, work with your doctor to set treatment goals to track your progress while on KEVEYIS.1

KEVEYIS common side effects1

It’s normal to experience certain side effects when you start taking KEVEYIS. Some side effects can be resolved with proper techniques or dose adjustment with the help of your doctor.1

Tingling or prickling sensations
(pins and needles)

Confusion or trouble paying attention

Changes in taste

Brain fog

Moving forward with PPP with KEVEYIS

Hear Dennis’s story about how KEVEYIS helped him gain more control over his PPP.

PATIENT TESTIMONIALS

Real KEVEYIS stories

Patients share their experience of taking KEVEYIS for PPP.
Paul
On KEVEYIS since 2017
“I went from about one [attack] a week to one a month since starting KEVEYIS.”

Paul
KEVEYIS patient
Hear more about Paul ➞
Kirsten
On KEVEYIS since 2016
“After starting KEVEYIS I have no attacks of full body paralysis.”

Kirsten
KEVEYIS patient
Hear more about Kirsten ➞
Dennis
On KEVEYIS since 2016
“Before KEVEYIS, I was having a lot of episodes…it was horrible. [After starting KEVEYIS], I haven’t had a serious attack in years.”

Dennis
KEVEYIS patient
Hear more about Dennis ➞
Janine
On KEVEYIS since 2016
“Having more control over my symptoms on KEVEYIS I feel more confident, more independent.”

Janine
KEVEYIS patient
Hear more about Janine ➞

Take the next step

Find out if KEVEYIS is right for you — and see for yourself the difference it can make.

By submitting this form, I understand I am giving Xeris Pharmaceuticals, Inc., its affiliates, and business partners permission to use the personal information provided in this registration form to contact me by the following methods, but not limited to: mail, email, telephone call or in-person about disease and product information, disease or product-related events, support services, market research, and to share promotional and marketing information. By submitting this form, I consent to these uses and am confirming that I have read and agree to the Xeris Pharmaceuticals® Terms of Use and Privacy Statement. I understand I can unsubscribe by clicking on the unsubscribe link in future communications or by sending a letter with my full contact information (eg, name, address, email, phone, etc) to Xeris CareConnection™ Patient Support Services, 1375 W Fulton Street, Suite 1300, Chicago, IL 60607.

Thank you!

We’ve received your message and will be in touch shortly.

References

  1. KEVEYIS [package insert]. Chicago, IL; Xeris Pharmaceuticals.
  2. Sansone VA, Burge J, McDermott MP, et al; for the Muscle Study Group. Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis. Neurology. 2016;86:1408-1416.
  3. Tawil R, McDermott MP, Brown R, et al. Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis. Ann Neurol. 2000;47(1):46-53.

Find answers

Take the next step

Get customized support for your KEVEYIS journey. Simply fill out the information and a Patient Access Manager will contact you. They will walk you through the entire process, from diagnosis to treatment and beyond.

By submitting this form, I understand I am giving Xeris Pharmaceuticals, Inc., its affiliates, and business partners permission to use the personal information provided in this registration form to contact me by the following methods, but not limited to: mail, email, telephone call or in-person about disease and product information, disease or product-related events, support services, market research, and to share promotional and marketing information. By submitting this form, I consent to these uses and am confirming that I have read and agree to the Xeris Pharmaceuticals® Terms of Use and Privacy Statement. I understand I can unsubscribe by clicking on the unsubscribe link in future communications or by sending a letter with my full contact information (eg, name, address, email, phone, etc) to Xeris CareConnection™ Patient Support Services, 1375 W Fulton Street, Suite 1300, Chicago, IL 60607.

Thank you!

We’ve received your message and will be in touch shortly.